Sonoma Pharmaceuticals (SNOA) Change in Accured Expenses (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Change in Accured Expenses of -$362000.0 in Q4 2025, down 160.54% quarter-over-quarter from $598000.0 in Q3 2025, and down 552.5% on a YoY basis from $80000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$362000.0 for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 552.5% year-over-year to -$362000.0; the TTM figure through Dec 2025 stood at -$196000.0 (down 150.65% YoY), while the FY2025 annual figure was $194000.0, up 921.05% from the prior year.
- Change in Accured Expenses was -$362000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $598000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $598000.0 in Q3 2025 to a low of -$484000.0 in Q2 2025.
- Historically, Change in Accured Expenses has averaged $44100.0 across 5 years, with a median of $52500.0 in 2024.
- Biggest YoY gain for Change in Accured Expenses was 6544.44% in 2025; the steepest drop was 1013.21% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $306000.0 in 2021, then rose by 27.45% to $390000.0 in 2022, then slumped by 184.62% to -$330000.0 in 2023, then soared by 124.24% to $80000.0 in 2024, then sank by 552.5% to -$362000.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$362000.0 (Q4 2025), $598000.0 (Q3 2025), and -$484000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -362,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -362,000.00 |
| Dec 31, 2025 | -362,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Sep 30, 2023 | -76,000.00 |
| Sep 30, 2023 | -76,000.00 |